Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
SB 216763
Cat. No.:
OB0225LY-0350
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
SB 216763 is a selective GSK-3β inhibitor that contains different chemical moieties to enhance biological activity.
Synonym:
SB216763; 280744-09-4; 3-(2,4-Dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione; 3-(2,4-Dichlorophenyl)-4-(1-methylindol-3-yl)pyrrole-2,5-dione; 1H-Pyrrole-2,5-dione, 3-(2,4-dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-
CAS No.:
280744-09-4
Compound CID:
176158
Formula:
C19H12Cl2N2O2
Formula Weight:
371.22
Specification
Relative Density:
1.47 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
SB 216763 can be used in neurodegenerative disease research or play an important role in cell proliferation and differentiation studies.
Library Information
Targets:
GSK-3 family
Receptors:
GSK-3α; GSK-3β
Pathways:
Autophagy; PI3K/Akt/mTOR signaling; Stem cells
Plate Number:
AOCL-5
Plate Location:
e4
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
10 mg/mL; 26.94 mM
